tobramycin sulfate — CareFirst (Caremark)

Serious staphylococcal infections when penicillin or other less toxic drugs are contraindicated and bacterial susceptibility testing and clinical judgment indicate its use

Initial criteria

Bacterial cultures are obtained prior to and during treatment to identify etiologic organisms and test susceptibility to tobramycin
Patient has a proven or strongly suspected infection caused by bacteria susceptible to tobramycin
If causative organisms are resistant to tobramycin, other appropriate therapy should be used
In serious life‑threatening gram‑negative infections, tobramycin may be initiated empirically before susceptibility results are available; continuation must be based on susceptibility and clinical response